Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Testing the predictive ability of the "spinal cord injury equation" in estimating vancomycin clearance.

Lee JP, Wang YJ.

Am J Health Syst Pharm. 2013 Apr 15;70(8):669-74. doi: 10.2146/ajhp120329.

PMID:
23552044
[PubMed - indexed for MEDLINE]
2.

Evaluation of methods to estimate glomerular filtration rate versus actual drug clearance in patients with chronic spinal cord injury.

Lee JP, Dang AT.

Spinal Cord. 2011 Dec;49(12):1158-63. doi: 10.1038/sc.2011.82. Epub 2011 Jul 26.

PMID:
21788951
[PubMed - indexed for MEDLINE]
3.

Single-dose gentamicin clearance is a predictor of creatinine clearance in spinal man.

Segal JL, Gilman TA, Thompson JF.

Am J Ther. 2010 Jul-Aug;17(4):390-5. doi: 10.1097/MJT.0b013e3181a75c84.

PMID:
19531933
[PubMed - indexed for MEDLINE]
4.

Vancomycin pharmacokinetics in spinal cord injured patients: a comparison with age-matched, able-bodied controls.

Lavezo LA, Davis RL.

J Spinal Cord Med. 1995 Oct;18(4):233-5.

PMID:
8591068
[PubMed - indexed for MEDLINE]
5.

Clinical pharmacokinetics of gentamicin. Estimation of initial dosing parameters in hospitalized patients at Al-Amiri Hospital Kuwait.

Al-Lanqawi Y, Capps P, Abudlmalek K, Al-Anezi K, Thusu A, Sharma P.

Med Princ Pract. 2009;18(3):209-16. doi: 10.1159/000204352. Epub 2009 Apr 6.

PMID:
19349724
[PubMed - indexed for MEDLINE]
6.

Predictive performance of a vancomycin-aminoglycoside population model.

Beringer PM, Wong-Beringer A, Rho JP.

Ann Pharmacother. 1998 Feb;32(2):176-81.

PMID:
9496400
[PubMed - indexed for MEDLINE]
7.

[Bayesian forecasting of plasma vancomycin concentration using time-dependent pharmacokinetics].

Nakamura T, Wakaki N, Kimura Y, Goto N, Masada M.

Yakugaku Zasshi. 1996 Nov;116(11):876-83. Japanese.

PMID:
8981831
[PubMed - indexed for MEDLINE]
8.

Effect of various estimates of renal function on prediction of vancomycin concentration by the population mean and Bayesian methods.

Tsuji Y, Hiraki Y, Mizoguchi A, Sadoh S, Sonemoto E, Kamimura H, Karube Y.

J Clin Pharm Ther. 2009 Aug;34(4):465-72. doi: 10.1111/j.1365-2710.2008.01015.x.

PMID:
19583680
[PubMed - indexed for MEDLINE]
9.

Non steady state and steady state PKS Bayesian forecasting and vancomycin pharmacokinetics in ICU adult patients.

Polard E, Le Bouquin V, Le Corre P, Kérebel C, Trout H, Feuillu A, Le Verge R, Mallédant Y.

Ther Drug Monit. 1999 Aug;21(4):395-403.

PMID:
10442692
[PubMed - indexed for MEDLINE]
10.

Population pharmacokinetics of vancomycin in adult and geriatric patients: comparison of eleven approaches.

Sánchez JL, Dominguez AR, Lane JR, Anderson PO, Capparelli EV, Cornejo-Bravo JM.

Int J Clin Pharmacol Ther. 2010 Aug;48(8):525-33.

PMID:
20650044
[PubMed - indexed for MEDLINE]
11.

Vancomycin monitoring: one or two serum levels?

Andrés I, López R, Pou L, Piñol F, Pascual C.

Ther Drug Monit. 1997 Dec;19(6):614-9.

PMID:
9421100
[PubMed - indexed for MEDLINE]
12.

Vancomycin dosing assessment in intensive care unit patients based on a population pharmacokinetic/pharmacodynamic simulation.

Revilla N, Martín-Suárez A, Pérez MP, González FM, Fernández de Gatta Mdel M.

Br J Clin Pharmacol. 2010 Aug;70(2):201-12. doi: 10.1111/j.1365-2125.2010.03679.x.

PMID:
20653673
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Comparing two predictive methods for determining serum vancomycin concentrations at a Veterans Affairs Medical Center.

Lee E, Winter ME, Boro MS.

Am J Health Syst Pharm. 2006 Oct 1;63(19):1872-5.

PMID:
16990634
[PubMed - indexed for MEDLINE]
14.

Influence of glomerular filtration rate on the clearance of vancomycin administered by continuous infusion in burn patients.

Dailly E, Le Floch R, Deslandes G, Pannier M, Jolliet P.

Int J Antimicrob Agents. 2008 Jun;31(6):537-9. doi: 10.1016/j.ijantimicag.2008.02.008. Epub 2008 May 6.

PMID:
18462925
[PubMed - indexed for MEDLINE]
15.

Initial dosage regimens of vancomycin for Chinese adult patients based on population pharmacokinetic analysis.

Deng C, Liu T, Zhou T, Lu H, Cheng D, Zhong X, Lu W.

Int J Clin Pharmacol Ther. 2013 May;51(5):407-15. doi: 10.5414/CP201842.

PMID:
23458230
[PubMed - indexed for MEDLINE]
16.

Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia population.

Jarkowski A 3rd, Forrest A, Sweeney RP, Tan W, Segal BH, Almyroudis N, Wang ES, Wetzler M.

J Oncol Pharm Pract. 2012 Mar;18(1):91-6. doi: 10.1177/1078155211402107. Epub 2011 Apr 26.

PMID:
21521799
[PubMed - indexed for MEDLINE]
17.

Pharmacology of riluzole in acute spinal cord injury.

Chow DS, Teng Y, Toups EG, Aarabi B, Harrop JS, Shaffrey CI, Johnson MM, Boakye M, Frankowski RF, Fehlings MG, Grossman RG.

J Neurosurg Spine. 2012 Sep;17(1 Suppl):129-40. doi: 10.3171/2012.5.AOSPINE12112.

PMID:
22985379
[PubMed - indexed for MEDLINE]
18.

Predictability of vancomycin trough concentrations using seven approaches for estimating pharmacokinetic parameters.

Murphy JE, Gillespie DE, Bateman CV.

Am J Health Syst Pharm. 2006 Dec 1;63(23):2365-70.

PMID:
17106010
[PubMed - indexed for MEDLINE]
19.

Are higher vancomycin doses needed in ventricle-external shunted patients?

Pujal M, Soy D, Codina C, Ribas J.

Pharm World Sci. 2006 Aug;28(4):215-21. Epub 2006 Oct 26.

PMID:
17066239
[PubMed - indexed for MEDLINE]
20.

Accuracy of Bayesian, Sawchuk-Zaske, and nomogram dosing methods for vancomycin.

Garrelts JC, Godley PJ, Horton MW, Karboski JA.

Clin Pharm. 1987 Oct;6(10):795-9.

PMID:
3505841
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk